Author:
Zhan Honglei,Liang Jun F.
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. Min, K. H. et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 127, 208–218 (2008).
2. Gallo, R. C., Whang-Peng, J. & Adamson, R. H. Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. J Natl Cancer Inst 46, 789–795 (1971).
3. Berrada, M. et al. A novel non-toxic camptothecin formulation for cancer chemotherapy. Biomaterials 26, 2115–2120 (2005).
4. Rothenberg, M. L. Topoisomerase I inhibitors: Review and update. Annals of Oncology 8, 837–855 (1997).
5. Hertzberg, R. P., Caranfa, M. J. & Hecht, S. M. On the mechanism of topoisomerase-I inhibition by camptothecin - evidence for binding to an enzyme DNA complex. Biochemistry 28, 4629–4638 (1989).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献